Literature DB >> 19258943

The fallopian tube: primary site of most pelvic high-grade serous carcinomas.

Shannon Salvador1, Blake Gilks, Martin Köbel, David Huntsman, Barry Rosen, Dianne Miller.   

Abstract

Epithelial ovarian cancer is the most common cause of mortality from gynecologic malignancy, and most of epithelial cancers are of serous type. The site of origin of pelvic high-grade serous carcinoma has been the subject of debate for 60 years. This paper reviews the evidence that pelvic serous carcinoma originates from the fallopian tube mucosa and puts forward a theory that inflammation in the tube, caused by menstrual cytokines or infection, is critical to the genesis of these tumors. Other risk factors for pelvic serous carcinoma will be reviewed, including oral contraceptive use, parity, infertility, and tubal ligation.Studies were identified for this review by searching the English language literature in the MEDLINE database between the years 1995 and 2007 using the following keywords: fallopian tube neoplasia, ovarian serous adenocarcinoma, pregnancy, oral contraceptive, infertility, pelvic inflammatory disease, cytokines, menstruation, and tubal ligation, followed by an extensive review of bibliographies from articles found through the search.The clinical implications of this theory are discussed, and a change in surgical practice is recommended, with salpingectomy at the time of simple hysterectomy. This theory also has implications for the development of new methods of screening for pelvic serous carcinomas, as there are no screening methods that are currently available to find this form of cancer in an early stage. Inflammatory markers could be detected in the vagina from the fallopian tube indicating possible chronic inflammation and a risk factor for mutagenesis leading to serous carcinoma.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19258943     DOI: 10.1111/IGC.0b013e318199009c

Source DB:  PubMed          Journal:  Int J Gynecol Cancer        ISSN: 1048-891X            Impact factor:   3.437


  47 in total

1.  Screening for ovarian cancer: imaging challenges and opportunities for improvement.

Authors:  K B Mathieu; D G Bedi; S L Thrower; A Qayyum; R C Bast
Journal:  Ultrasound Obstet Gynecol       Date:  2018-03       Impact factor: 7.299

2.  Examining the use of salpingectomy with hysterectomy in Canada.

Authors:  C Sandoval; M Fung-Kee-Fung; B Gilks; K J Murphy; R Rahal; H Bryant
Journal:  Curr Oncol       Date:  2013-06       Impact factor: 3.677

3.  The origin and pathogenesis of epithelial ovarian cancer: a proposed unifying theory.

Authors:  Robert J Kurman; Ie-Ming Shih
Journal:  Am J Surg Pathol       Date:  2010-03       Impact factor: 6.394

4.  Primary culture and immortalization of human fallopian tube secretory epithelial cells.

Authors:  Alison M Karst; Ronny Drapkin
Journal:  Nat Protoc       Date:  2012-08-30       Impact factor: 13.491

5.  Long term follow up of BRCA1 and BRCA2 mutation carriers with unsuspected neoplasia identified at risk reducing salpingo-oophorectomy.

Authors:  C B Powell; E M Swisher; I Cass; J McLennan; B Norquist; R L Garcia; J Lester; B Y Karlan; L Chen
Journal:  Gynecol Oncol       Date:  2013-02-04       Impact factor: 5.482

6.  Secretory cell outgrowth, PAX2 and serous carcinogenesis in the Fallopian tube.

Authors:  Eleanor Y Chen; Karishma Mehra; Mitra Mehrad; Gang Ning; Alexander Miron; George L Mutter; Nicholas Monte; Bradley J Quade; Frank D McKeon; Yosuf Yassin; Wa Xian; Christopher P Crum
Journal:  J Pathol       Date:  2010-09       Impact factor: 7.996

7.  Primary sources of pelvic serous cancer in patients with endometrial intraepithelial carcinoma.

Authors:  Lin Jia; Zeng Yuan; Yiying Wang; Janiel M Cragun; Beihua Kong; Wenxin Zheng
Journal:  Mod Pathol       Date:  2014-06-13       Impact factor: 7.842

8.  Inhibitory role of prohibitin in human ovarian epithelial cancer.

Authors:  Lin Jia; Jian-Min Ren; Yi-Ying Wang; Yu Zheng; Hui Zhang; Qing Zhang; Bei-Hua Kong; Wen-Xin Zheng
Journal:  Int J Clin Exp Pathol       Date:  2014-04-15

9.  Public perception of risk-reducing salpingectomy for preventing ovarian cancer.

Authors:  Jun Hyeok Kang; Se Hyun Nam; Taejong Song; Woo Young Kim; Kyo Won Lee; Kye Hyun Kim
Journal:  Obstet Gynecol Sci       Date:  2015-07-16

10.  Bcl-2 expression is altered with ovarian tumor progression: an immunohistochemical evaluation.

Authors:  Nicole S Anderson; Leslie Turner; Sandra Livingston; Ren Chen; Santo V Nicosia; Patricia A Kruk
Journal:  J Ovarian Res       Date:  2009-10-25       Impact factor: 4.234

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.